ArticleJournal of oncology2022

Low Expression of CD5 and CD6 Is Associated with Poor Overall Survival for Patients with T-Cell Malignancies.

Songnan Sui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.